 Efficacy fludarabine new adenine analogue patients prolymphocytic leukemia prolymphocytoid variant chronic lymphocytic leukemia PURPOSE results fludarabine therapy patients prolymphocytic leukemia PLL prolymphocytoid variant chronic lymphocytic leukemia CLL-Pro PATIENTS METHODS Seventeen patients diagnosis PLL CLL-Pro fludarabine minutes days weeks patients prednisone patients criteria response Differences response rates various characteristics chi-square test RESULTS patients complete remission partial remission overall response rate Responses durable organ sites response rates patients anemia thrombocytopenia Rai stages primary resistance therapy Toxicities minimal febrile episodes therapy CONCLUSION Fludarabine encouraging results patients investigation combination active agents setting front-line therapy